SMAD3 and neoplasm: We injected the cells into the IL6−/− mice through tail vein injection to prevent confounding effects from the host IL‐6 and determined the impact of IL‐6 KO in SMAD3‐mediated tumor metastasis (Figure S8D, Supporting Information).